This website is intended for UK healthcare professionals only

Overview of NICE Technology Appraisal 375: adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed

Disclaimer: Information intended for healthcare professionals only. This supplement has been developed and funded by Bristol-Myers Squibb. Bristol-Myers Squibb commissioned the production of the supplement. The content has been checked by Bristol-Myers Squibb for factual accuracy, to ensure it is fair and balanced, and to ensure its compliance with appropriate regulations. The NICE guidance and content provided on pp.3–5 are reproduced with permission of NICE. Copyright in the guidance rests with NICE, and it may be freely reproduced for educational and not-for-profit purposes. No reproduction by, or for, commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE. The content included in this supplement only displays the concise technology appraisal; readers are strongly advised to refer to the full appraisal at guidance.nice.org.uk/TA375 and to current NICE guidance on rheumatoid arthritis at: pathways.nice.org.uk/pathways/rheumatoid-arthritis The prescribing information on page 7 and the advertisement feature on page 8 were provided by Bristol-Myers Squibb.



Choosing an appropriate inhaler device for the treatment of adults with asthma or COPD
Development Group: Usmani, Capstick, Chowhan, & Scullion.
This management algorithm was developed by a multidisciplinary expert panel: Usmani O et al with the support of a grant from Chiesi Ltd.

Management of asthma in adults over 65 years of age
Development group: Gruffydd-Jones, McArthur, Murphy, Russell & Wise.
This management algorithm was developed by a multidisciplinary expert panel: Gruffydd-Jones K et al with the support of a grant from Teva UK Limited.

Low back pain and sciatica in over 16s: assessment and management
National Institute for Health and Care Excellence

Chest pain of recent onset: assessment and diagnosis
National Institute for Health and Care Excellence

Choosing an appropriate inhaler device for the treatment of adults with asthma or COPD
Development Group: Usmani, Capstick, Chowhan, & Scullion.
This management algorithm was developed by a multidisciplinary expert panel: Usmani O et al with the support of a grant from Chiesi Ltd.

Low back pain and sciatica in over 16s: assessment and management
National Institute for Health and Care Excellence

Tinnitus guidance for GPs
British Tinnitus Association

Chest pain of recent onset: assessment and diagnosis
National Institute for Health and Care Excellence



Visit our NEW site!

Guidelines for Nurses provides current, credible summaries and feature articles developed especially for nurses.